Ginsenoside-Rg1 induces angiogenesis via non-genomic crosstalk of glucocorticoid receptor and fibroblast growth factor receptor-1

Cardiovascular Research

Volumn 89, Issue 2, 2011, Pages 419-425

  Cheung, Lydia W T ^a   Leung, Kar Wah ^a   Wong, Chris K C ^b   Wong, Ricky N S ^b   Wong, Alice S T ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

ENOS; Ginseng; HUVEC; PI3K Akt; Signalling

Indexed keywords

BETA ACTIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GINSENOSIDE RG 1; GLUCOCORTICOID RECEPTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MIFEPRISTONE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA;

ANGIOGENESIS; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVATION; GENE EXPRESSION; GINSENG; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ANGIOGENESIS INDUCING AGENTS; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GINSENOSIDES; HORMONE ANTAGONISTS; HUMANS; MIFEPRISTONE; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; PYRROLES; RECEPTOR CROSS-TALK; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, GLUCOCORTICOID; RNA INTERFERENCE;

EID: 78751471555     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq300     Document Type: Article

References (30)

1. Folkman J. Angiogenesis and proteins of the hemostatic system. J Thromb Haemost 2003;1:1681-1682.
2. Folkman J, Ingber DE. Angiostatic steroids. Method of discovery and mechanism of action. Ann Surg 1987;206:374-383.
3. Reddy TE, Pauli F, Sprouse RO, Neff NF, Newberry KM, Garabedian MJ et al. Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome Res 2009;19:2163-2171.
4. Jia L, Zhao Y. Current evaluation of the millennium phytomedicine-ginseng (I): etymology, pharmacognosy, phytochemistry, market and regulations. Curr Med Chem 2009;16:2475-2484.
5. Chen C, Chiou W, Zhang J. Comparison of the pharmacological effects of Panax ginseng and Panax quinquefolium. Acta Pharmacol Sin 2008;29:1103-1108.
6. Sengupta S, Toh SA, Sellers LA, Skepper JN, Koolwijk P, Leung HW et al. Modulating angiogenesis: the yin and the yang in ginseng. Circulation 2004;110:1219-1225.
7. Lee YJ, Chung E, Lee KY, Lee YH, Huh B, Lee SK. 3Ginsenoside-Rg1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor. Mol Cell Endocrinol 1997;133:135-140.
8. Leung KW, Cheng YK, Mak NK, Chan KK, Fan DY, Wong RN. Signaling pathway of ginsenoside-Rg1 leading to nitric oxide production in endothelial cells. FEBS Lett 2006;580:3211-3216.
9. Leung KW, Pon YL, Wong RN, Wong AS. Ginsenoside-Rg1 induces vascular endothelial growth factor expression through the glucocorticoid receptor-related phosphatidylinositol 3-kinase/Akt and beta-catenin/T-cell factor-dependent pathway in human endothelial cells. J Biol Chem 2006;281:36280-36288.
10. Song IH, Buttgereit F. Non-genomic glucocorticoid effects to provide the basis for new drug developments. Mol Cell Endocrinol 2006;246:142-146.
11. Kim DW, Lu B, Hallahan DE. Receptor tyrosine kinase inhibitors as anti-angiogenic agents. Curr Opin Investig Drugs 2004;5:596-604.
12. Duda DG, Fukumura D, Jain RK. Role of eNOS in neovascularization: NO for endothelial progenitor cells. Trends Mol Med 2004;10:143-145.
13. Antoine M, WirzW, Tag CG, Mavituna M, Emans N, Stoldt V et al. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells. Growth Factors 2005;23:87-95.
14. Madri JA, Pratt BM, Tucker AM. Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J Cell Biol 1988;106:1375-1384.
15. Makara GB, Haller J. Non-genomic effects of glucocorticoids in the neural system. Evidence, mechanisms and implications. Prog Neurobiol 2001;65:367-390.
16. Hafezi-Moghadam A, Simoncini T, Yang E, Limbourg FP, Plumier JC, Rebsamen MC et al. Acute cardiovascular protective effects of corticosteroids are mediated by nontranscriptional activation of endothelial nitric oxide synthase. Nat Med 2002;8: 473-479. (Pubitemid 34546749)
17. Sellke FW, Wang SY, Stamler A, Lopez JJ, Simons M. Enhanced microvascular relaxations to VEGF and bFGF in chronically ischemic porcine myocardium. Am J Physiol Heart Circ Physiol 1996;271:H713-H720.
18. Zhang H, Issekutz AC. Growth factor regulation of neutrophil-endothelial cell interactions. J Leukoc Biol 2001;70:225-232.
19. Hricovini M, Guerrini M, Bisio A, Torri G, Naggi A, Casu B. Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution. Semin Thromb Hemost 2002;28:325-334.
20. Gametchu B, Watson CS. Correlation of membrane glucocorticoid receptor levels with glucocorticoid-induced apoptotic competence using mutant leukemic and lymphoma cells lines. J Cell Biochem 2002;87:133-146.
21. Bartholome B, Spies CM, Gaber T, Schuchmann S, Berki T, Kunkel D et al. Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis. FASEB J 2004;18:70-80.
22. Javerzat S, Auguste P, Bikfalvi A. The role of fibroblast growth factors in vascular development. Trends Mol Med 2002;8:483-489.
23. Migliaccio A, Castoria G, Di Domenico M, Ciociola A, Lombardi M, De Falco A et al. Crosstalk between EGFR and extranuclear steroid receptors. Ann N Y Acad Sci 2006; 1089:194-200.
24. Brostjan C, Anrather J, Csizmadia V, Stroka D, Soares M, Bach FH et al. Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis. J Biol Chem 1996;271:19612-19616.
25. Solito E, Mulla A, Morris JF, Christian HC, Flower RJ, Buckingham JC. Dexamethasone induces rapid serine-phosphorylation and membrane translocation of annexin 1 in a human folliculostellate cell line via a novel nongenomic mechanism involving the glucocorticoid receptor, protein kinase C, phosphatidylinositol 3-kinase, and mitogenactivated protein kinase. Endocrinology 2003;144:1164-1174.
26. Croxtall JD, Choudhury Q, Flower RJ. Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptordependent, transcription-independent mechanism. Br J Pharmacol 2000;130:289-298.
27. Kojda G, Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res 1999;43:562-571.
28. Lee K, Wang H, Itokawa H, Morris-Natschke SL. Current perspective on Chinese medicines and dietary supplements in China, Japan, and the United States. J Food Drug Anal 2000;8:219-228.
29. Xu QF, Fang XL, Chen DF. Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats. J Ethnopharmacol 2003;84:187-192.
30. Han M, Fang XL. Difference in oral absorption of ginsenoside Rg1 between in vitro and in vivo models. Acta Pharmacol Sin 2006;27:499-505.